About AbCheck
  AbCheck provides a unique source of therapeutic antibodies with one of the industry's most versatile technology platforms. We provide high-quality drug candidates through discovery collaborations or strategic research partnerships based on flexible business terms including royalty-free deals.

Offering both natural and engineered libraries, AbCheck strives to meet partners’ demands from across the biopharmaceutical industry. We generate target specific human antibody domains which can be used in different therapeutic formats. Over 30 collaborative projects have delivered the validation of AbCheck’s platform and capabilities and yielded in several clinical-stage programs.

AbCheck originates from a 2009 spin-out of the technology discovery platform out of Affimed, a biopharmaceutical company developing highly targeted cancer immunotherapies.
  Download the Company Presentation
  Download the Company Factsheet
  Imprint Disclaimer